Finance

Beta
Lists
300039:SHE
Shanghai Kaibao Pharmaceutical Co Ltd
CN¥4.46
-10.80%
(-0.54) 1D
Jun 10, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300039...
Open
CN¥4.81
High
CN¥4.81
Low
CN¥4.34
Mkt. cap
5.23B
Avg. vol.
8.09M
Volume
41.34M
Dividend
2.91%
Quarterly dividend
CN¥0.03
Ex-dividend date
May 29, 2026
P/E ratio
18.00
52-wk high
CN¥7.03
52-wk low
CN¥4.34
EPS
CN¥0.25
Shares outstanding
1.05B
No. of employees
1K
Open
CN¥4.81
High
CN¥4.81
Low
CN¥4.34
Mkt. cap
5.23B
Avg. vol.
8.09M
Volume
41.34M
Dividend
2.91%
Quarterly dividend
CN¥0.03
Ex-dividend date
May 29, 2026
P/E ratio
18.00
52-wk high
CN¥7.03
52-wk low
CN¥4.34
EPS
CN¥0.25
Shares outstanding
1.05B
No. of employees
1K
News stories
From sources across the web
About Shanghai Kaibao Pharmaceutical Co Ltd
CEO-
Employees1.2K
FoundedApr 12, 2000
Headquarters-
SectorPharmaceutical industry
Websitexykb.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
204.02M
214.37M
333.63M
283.25M
Cost of goods sold
41.75M
43.67M
64.49M
54.33M
Cost of revenue
41.75M
43.67M
64.49M
54.33M
Research and development expenses
26.39M
8.86M
25.01M
19.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.13M
106.04M
148.00M
137.79M
Operating expense
131.15M
114.94M
185.39M
159.80M
Total operating expenses
172.90M
158.60M
249.87M
214.13M
Operating income
31.12M
55.77M
83.76M
69.12M
Other non operating income
-3.75K
-23.48K
-14.50K
-15.08K
EBT including unusual items
41.24M
75.82M
101.69M
77.06M
EBT excluding unusual items
40.59M
74.92M
104.13M
77.58M
Income tax expense
3.68M
10.85M
10.35M
12.31M
Effective tax rate
8.92%
14.31%
10.18%
15.97%
Other operating expenses
3.53M
202.62K
8.82M
4.21M
Net income
37.66M
65.09M
91.54M
64.87M
Net profit margin
18.46%
30.36%
27.44%
22.90%
Earnings per share
-
-
-
-
Interest and investment income
9.50M
19.21M
20.41M
8.51M
Interest expense
-22.54K
-32.96K
-21.18K
-39.73K
Net interest expenses
9.48M
19.17M
20.39M
8.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
39.44M
64.62M
92.13M
77.49M
Gain or loss from assets sale
-187.25K
187.25K
-39.32K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more